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ABSTRACT
Introduction: The aim of this study was to assess the epidemiological and operational 
characteristics of the Leprosy Program before and after its integration into the Primary 
healthcare Services of the municipality of Aracaju-Sergipe, Brazil. Methods: Data were drawn 
from the national database. The study periods were divided into preintegration (1996-2000) 
and postintegration (2001-2007). Annual rates of epidemiological detection were calculated. 
Frequency data on clinico-epidemiological variables of cases detected and treated for the two 
periods were compared using the Chi-squared (χ2) test adopting a 5% level of significance. 
Results: Rates of detection overall, and in subjects younger than 15 years, were greater for 
the postintegration period and were higher than rates recorded for Brazil as a whole during 
the same periods. A total of 780 and 1,469 cases were registered during the preintegration 
and postintegration periods, respectively. Observations for the postintegration period were as 
follows: I) a higher proportion of cases with disability grade assessed at diagnosis, with increase 
of 60.9% to 78.8% (p < 0.001), and at end of treatment, from 41.4% to 44.4% (p < 0.023); 
II) an increase in proportion of cases detected by contact examination, from 2.1% to 4.1% 
(p < 0.001); and III) a lower level of treatment default with a decrease from 5.64 to 3.35 
(p < 0.008). Only 34% of cases registered from 2001 to 2007 were examined. Conclusions: 
The shift observed in rates of detection overall, and in subjects younger than 15 years, during 
the postintegration period indicate an increased level of health care access. The fall in number 
of patients abandoning treatment indicates greater adherence to treatment. however, previous 
shortcomings in key actions, pivotal to attaining the outcomes and impact envisaged for the 
program, persisted in the postintegration period.
Keywords: Leprosy. Epidemiology. Program and project evaluation. Family health. Primary 
health care.
RESUMO
Introdução: O estudo avalia características epidemiológicas e operacionais do programa de 
hanseníase no período anterior e posterior à integração nos serviços de Atenção Primária do 
município de Aracaju-Sergipe, Brasil. Métodos: Os dados foram obtidos da base nacional. 
O período estudado foi dividido em pré-integração (1996-2000) e pós-integração (2001-
2007). Calcularam-se os indicadores epidemiológicos de detecção ano a ano. Frequências de 
variáveis clínico-epidemiológicas dos casos detectados e tratados foram comparadas entre os 
dois períodos utilizando-se qui-quadrado (χ2) com nível de significância de 5%. Resultados: 
As taxas de detecção geral e em menores de 15 anos aumentaram no pós-integração e se 
mantiveram acima das obtidas para o Brasil em ambos os períodos. houve 780 e 1.469 casos 
nos períodos pré e pós-integração, respectivamente. No período pós-integração, observou-
se: aumento na proporção de casos com grau de incapacidade avaliado ao diagnóstico, de 
60,9% para 78,8% (p < 0,001) e, ao final do tratamento, de 41,4% para 44,4% (p < 0,023); 
aumento na proporção de casos detectados por exame de contatos, de 2,1% para 4,1% 
(p < 0,001); diminuição do abandono de tratamento de 5,64 para 3,35 (p < 0,008). Apenas 34% 
dos contatos registrados nos anos 2001-2007 foram examinados. Conclusões: As oscilações 
verificadas nas taxas de detecção geral e em menores de 15 anos no período pós-integração 
sugerem ter havido incremento no acesso. A redução do número de abandonos indica melhora 
na adesão ao tratamento. Insuficiências pré-existentes em ações de importância crucial para os 
resultados e impactos esperados do programa persistiram no período pós-integração.
Palavras-chaves: hanseníase. Epidemiologia. Avaliação de programas e projetos. Saúde da 
família. Atenção primária.
In Brazil, actions for diagnosing and treating 
leprosy have historically been conducted at 
specialized state-run units. Since 1994, Brazil’s 
Ministry of health has devised and promoted the 
Family health Strategy (FhS) as a priority model for 
organizing primary health care services. In response 
to initiatives by the World health Organization 
(WhO) recommending integration of leprosy 
control into primary health care (PhC), Brazil has 
established the integration of leprosy control actions 
(LCA) into primary health care as a key directive 
toward achieving the goal of eliminating leprosy1. 
Thus, the main strategy proposed for implementing 
leprosy actions was training family health care teams 
(FhCT), through training courses and distribution 
of technical guides.
The FhS was implemented in Acaraju in 19982. 
Integration of the LCA began only in 2000 following 
training of FhCT3. In 2007, the municipality 
had 128 FhCT, distributed among 43 family 
health units, providing coverage for 86.7% of the 
population2.
Traditionally, appraisals of the performance of 
the Leprosy Control Program (LCP) have been 
based on a set of indicators defined by the National 
LCP, compiled from information contained in 
notification/investigation records held on the 
Brazilian Disease Notification System (Sistema de 
Informação de Agravos de Notificação - SINAN), 
a system developed in the 1990s as a tool for 
collecting, processing, storing, and analyzing data 
on mandatory notifiable diseases in Brazil4. These 
indicators are categorized into two groups denoted 
by the Ministry of health as epidemiologic and 
operational5. however, the use of these indicators 
for assessment purposes has several drawbacks. 
One of these weaknesses is the lack of robustness 
of the information sourced from data collected at 
local and municipal levels. Many municipalities 
lack adequate systems to oversee data entry into 
the system or to monitor the information held. 
Nevertheless, for states and municipalities in which 
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the system is well managed, the assessment of information from the 
system enables valuable analyses, which help managers assess and 
monitor local actions6.
In this regard, the use of data from SINAN for individual 
municipalities and locales is potentially positive. Reports have 
described highly heterogeneous situations among different 
municipalities from within the same area or even across services 
offered by the same municipality. Greater proximity of the action 
agents, namely, health care managers and professionals, with 
these data increases the likelihood of the information leading to 
improvements.
The aim of the present study was to analyze the epidemiological 
indicators and the clinico-epidemiological characteristics of leprosy 
during the preintegration and postintegration periods of LCA at family 
health units in the municipality of Aracaju.
This descriptive study involved analysis spanning 12 years (Jan 1996 
to Dec 2007) and was restricted to diagnosed cases of leprosy in patients 
residing in the municipality of Aracaju in Sergipe, Brazil. Data were 
sourced from the SINAN through the Aracaju Municipal Secretariat for 
health and the State Secretariat for health of Sergipe. In a bid to increase 
the reliability of the data and reduce the risk of under-registration, 
the study used data collected in 2009 on the years 1996 to 2007.
Aracaju, the capital of State of Sergipe, covers an area of 174km2 
and had an estimated population of 544,035 inhabitants in 2009. 
The city accounts for the highest number of leprosy cases in the state 
and had an overall detection rate of 49.22 cases for every 100,000 
inhabitants in 20077. The integration of the LCP into family health 
units commenced in 20003, and therefore, the analysis was split 
into two study periods: the 1996 to 2000 period corresponded to 
the phase prior to the integration of the LCA and was denoted the 
preintegration period, and the period spanning from 2001 to 2007 
represented the postintegration period.
The database was organized to ensure exclusion of duplicate and 
inconsistent records. Individual compulsory notification records 
and/or clinical charts were analyzed in the remaining cases of 
inconsistencies. To standardize the records for current classification, 
cases with a disability grade 3, registered up to 2001, were converted 
to grade 2 disability, in accordance with the instrument standardized 
by the WhO, revised in 1998, and adopted in Brazil.
Given that leprosy detection rates fluctuate over longer periods, 
to assess the endemic picture for the municipality, a descriptive 
analysis of  the indicators recommended for monitoring and assessing 
the epidemic, compiled on an annual basis encompassing aspects of 
morbidity, magnitude, and epidemiological profile, was carried out5.
The following indicators were included: annual rate of detection 
of new cases per 100,000 inhabitants, annual rate of detection of new 
cases in the population aged between 0 and 14 years per 100,000 
inhabitants5, and proportion of disability grade 2 in new cases per 1 
million inhabitants at time of diagnosis8. Because of the inconsistency 
of some of the variables held on the database, the following indicators 
were excluded: proportion of leprosy cases with grade 2 physical 
disability on diagnosis among new cases detected and assessed 
on an annual basis and proportion of leprosy cases with grade 
2 physical disability among cases assessed at conclusion of 
multidrug therapy (MDT) on an annual basis. It was decided not to 
use the rate of annual prevalence of leprosy per 10,000 inhabitants 
because of the change in the criteria used to calculate this figure 
during the study period and also owing to the intrinsic weakness in 
the prevalence indicator currently in use.
From the year of initial diagnosis, the clinico-epidemiological 
variables were taken (gender, age-group, operational classification, 
disability grading (DG) rating at diagnosis, DG rating at end of 
treatment (MDT), detection method, contacts examined, and case 
outcome) as a proxy representing the quality of the service. The 
evolution of these variables over time was analyzed for the two 
time frames studied. The first period was the preintegration stage, 
characterized by a health care service centralized at a single health 
unit, whereas the second encompassed the postintegration period, 
during which, the LCA were integrated into PhC.
Data were stored on the EpiInfo™ software program, version 
3.3, from the Centers for Disease Control and Prevention (CDC), 
October 2004. Frequency distributions were compared using the 
Chi-squared (χ2) test adopting a 5% level of significance (p < 0.05). 
Ethical considerations
The project was previously approved by the Research Ethics 
Committee of the Clinics hospital, University of São Paulo Medical 
School (no 1032/08) and by the Research Ethics Committee of 
Tiradentes University (no 030108).
Detection rates
From 1996 to 2007, a total of 2,249 cases of leprosy were 
detected in Aracaju, the municipality with the highest number of 
cases of the disease in Sergipe. Table 1 shows data obtained by this 
study set against official figures on the epidemic in Brazil9. Shifts 
over the period point to an increase in overall detection during the 
years subsequent to integration of the LCP in PhC in 2000. A peak 
in detection was found in 2003, reaching a rate of over 50/100,000 
inhabitants, a level maintained for the two proceeding years.
The raw rates of detection in individuals between 0 and 14 years 
of age showed some variations, predominantly during the period 
following integration, peaking both in 2002 and 2005 when the 
detection rate reached its highest point of more than double the 
rate for the previous year. The trend in the detection rate in children 
revealed a pattern of a slight rise, where rates for Sergipe consistently 
exceeded those of Brazil as a whole for almost all years studied9.
Taken together, the overall detection rate between 2003 and 2006, 
plus the detection rate among individuals younger than 15 years, classify 
the municipality as hyper-endemic. During the other years studied, 
the pattern of the epidemic was classified as very high5. The shift in 
the epidemiological picture for the disease coincided with the rising 
number of FhCTs incorporated into PhC and with the intensifying of 
the process of implementing the FhS in the municipality.
The proportion of new cases rated as DG2 at diagnosis (per 
million inhabitants) was calculated only for years in which the DG 
percentage assessed at diagnosis exceeded 75%. For the years 2001, 
2002, 2003, 2005, and 2006, the proportion of cases (per million 
inhabitants) showed a stable pattern with rates of 14.95, 12.66, 27.1, 
16.04, and 11.87, respectively.
205
Rev Soc Bras Med Trop 45(2):203-208, mar-abr, 2012
TABLE 1 - Epidemiological indicators for leprosy from 1996 to 2007.
 Overall detection rate  Detection rate in individuals  
 (per 100,000 population) < 15 years (per100,000 population)
Period Year Brazil* Aracaju** Brazil* Aracaju**
Preintegration 1996 25.79 41.1 7.5 13.29
 1997 28.27 28.52 8.28 7.7
 1998 26.23 30.9 7.86 9.89
 1999 26.6 37.03 7.3 9.1
 2000 25.44 38.78 6.72 7.82
Postintegration 2001 26.61 31.81 6.96 5.39
 2002 28.33 35.65 7.47 13.7
 2003 29.37 53.56 7.98 13.54
 2004 28.24 50.04 7.68 15.61
 2005 26.86 51.94 7.34 18.09
 2006 23.37 41.95 6.22 8.57
 2007 21.19 35.16 6.07 6.94
*Brazil’s Ministry of health8. **Database used by the study.
TABLE 2 - Clinico-epidemiological variables by period of integration of leprosy control actions into health care 
services.
 1996-2000 2001-2007       p
Variable n % n % value* 
Disability grade at diagnosis (n = 2,249)
DG 0 and 1 457 58.6 1,090 74.2 < 0.001
DG 2 18 2.3 57 3.9 
unknown 305 39.1 322 21.9 
Total 780 100.0 1,469 100.0 
Disability grade at end of multidrug therapy (n = 2,249)
DG 0 and 1 321 41.15 631 42.95 < 0.023
DG 2 2 0.26 20 1.36 
unknown 457 58.59 818 55.68 
Total 780 100.0 1,469 100.0 
Detection method (n = 2,249)
contact examination 16 2.1 60 4.1 < 0.001
others 756 96.9 1,312 89.3 
unknown 8 1.0 97 6.6 
Total 780 100.0 1,469 100.0 
Treatment outcome (n = 2,213)
treatment completed 701 89.9 1,293 90.2 < 0.008
defaulter 44 5.6 48 3.4 
others 35 4.5 92 6.4 
Total 780 100.0 1,433 100.0 
DG: disability grading. * Pearson’s χ2  
Clinico-epidemiological characteristics of cases
With regard to gender for the study period as a whole, the cases 
were predominantly women, but the gender distribution for the two 
study periods did not differ significantly (p = 0.164).
Of the 2,249 cases included, 2,077 (92.4%) were older than 
fifteen years when first diagnosed. Comparing the two study 
periods, the proportion of leprosy patients aged between 0 and 
14 years was 8% and 7.32% for preintegration and postintegration 
periods, respectively, a difference not reaching statistical significance 
(p = 0.696). A total of 351/780 (45%) cases in the age bracket of 
20 to 44 years were diagnosed during the preintegration period versus 
707/1,469 (48.3%) during the postintegration period.
The majority of cases detected were of the paucibacillary (PB) 
type for both study periods. Although an increase in multi-bacillary 
(MB) cases was seen (from 36.2% to 40%), this difference was not 
statistically significant (p = 0.073).
Table 2 shows the epidemiological variables by period of LCA 
integration in the municipality.
The proportion of new cases with DG rated at diagnosis was 
60.9% and 78.1% for preintegration and postintegration periods, 
respectively. A decrease in the percentage of cases in which DG was 
not rated was found for the postintegration period (p < 0.001).
Analysis of DG assessment at end of treatment revealed that 
DG was not rated in 58.6% and 55.7% of cases during preintegration 
a n d  p o s t i nt e g ra t i o n  p e r i o d s , 
respectively, where the reduction in 
cases without registered disability 
reached statistical significance for the 
postintegration period (p < 0.023).
In terms of detection method, a 
significant association (p < 0.001) 
was found with probable increased 
detection by contact examination, 
following the integration of LCA to 
PhC. Entry to the system as relapsing 
was included in this study under the 
category of other methods of detection, 
and from 1996 to 2000, only 3/780 
(0.4%) of cases were entered as 
relapsing , whereas from 2001 to 
2007, 59/1,469 (4%) of cases were 
registered under this mode of entry 
(data not shown in Table 2).
With regard to the number of 
patients undergoing treatment during 
the years assessed, 106/780 (13.6%) 
and 1,014/1,469 (69%) of patients 
had their contacts registered during 
preintegration and postintegration 
periods, respectively. The proportion 
of contact examinations per new 
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DISCUSSION
leprosy case was 568/780 (0.73) during the preintegration period 
versus 2,100/1,469 (1.43) for the postintegration period, showing 
improved compliance with the contact examination action.
Concerning the type of outcome registered, a significant 
reduction in the percentage of defaulters was found for the 
postintegration period (p < 0.008).
Comparing raw rates of detection overall, from 1996 to 2007, 
the epidemic was consistently worse in Aracaju than in Brazil as a 
whole for virtually all years studied9. These results point to an overall 
increase in detection after the integration of the LCP into PhC.
Worldwide, the trend in the rates of detection of new cases showed 
no decline between 1995 and 200010, but a downward shift was evident 
from 2002 to 200811. In India, the country with the highest number 
of leprosy cases, the rate of detection steadily increased between 
1982 and 200212. A similar steady upward trend also has been seen in 
Latin America10. Brazil accounts for over 90% of cases found in South 
America, and detection rates between 1980 and 2004 showed a steady 
rise13,14 with levels set to fall from 201013. For the North-East region 
of Brazil in particular, the largest increase in detection rates occurred 
between 1980 and 2004, although this area also had a higher regression 
rate than any other region in the country14.
The upward shift in detection rates seen in Aracaju is similar to 
the trend reported in other Brazilian studies15-19, but a steady decline 
is evident from 2003 onward. These results contrast with the pattern 
reported for states in the process of eliminating the disease as a public 
health problem, such as Paraná20 and São Paulo21, which exhibited a 
pattern of steady decline in detection rates over the same time frame.
The relatively stable pattern of detection rates in individuals 
between 0 and 14 years of age, with a marked rise during the 
postintegration period, is consistent with a study conducted in Duque 
de Caxias where twin peaks of detection were identified in this age 
group. This double-peak pattern may be explained by the initial phase 
of integration or strategic actions carried out the previous year16.
Other studies in Brazil involving individuals younger than 
15 years have revealed a pattern of endemicity varying from average 
to very high18,22,23. Rates for the Vale do Jequitinhonha were found to 
exceed those State of Minas Gerais, where parameters for the region 
were responsible for sustaining the epidemic and contributed to its 
classification of high to very high24. In the State of Espírito Santo, 
analysis of the trend of detection in individuals under 15 years of 
age showed an upward pattern between 1980 and 2003, with rates 
stabilizing between 1996 and 200319. Although other studies have 
shown similar slight increases in detection in children25 or have 
pointed to a steady pattern over time26, a study in a historic series 
performed in Bahia is noteworthy. The cited study found a substantial 
increase in the rate of detection among minors over the past two 
decades 15, demonstrating the recent surge in transmission of the 
epidemic5.
Frequency of new cases with DG 2 at diagnosis is a recent 
measure currently calculated per 1 million inhabitants8, which is 
employed to assess the magnitude of deformity caused by leprosy in 
the general population, to compare it against other diseases, and to 
indicate the efficacy of early case detection5. The measure currently 
lacks parameters defined by WhO or the Brazilian Ministry of health 
to aid its interpretation. Nevertheless, the world target is to reduce 
this figure by at least 35% between 2011 and 2015, whereas the target 
for Brazil is a 13% reduction from 2008 to 20155. Despite the accuracy 
issues associated with this indicator because of the characteristics 
of the epidemic and to the limited knowledge of the operational 
reality of actions in each country, the measure can contribute 
toward improving the quality of leprosy services27. The limitation 
of this study in interpreting this indicator may be attributable to 
the lack of data or to the under-reporting of physical disabilities at 
diagnosis, particularly from 1996 to 2000, during which time, the 
mean percentage of DG assessment was less than 75%. however, 
inconsistencies in data regarding disability registration, particularly in 
the first few years of the series analyzed, must be taken into account.
Biological and sociocultural factors have been implicated as 
determinants of the greater incidence of leprosy found in men28. 
Other studies carried out in Brazil have confirmed the disease’s 
predominance in male subjects19,29-31. however, the greater number of 
women found in the years assessed in the present study is in line with 
the findings of other investigations16,32-35. One possible explanation 
for this phenomenon is that traditionally, women have a tendency 
to seek PhC assistance more readily than men28,36. This difference is 
due to cultural gender issues (men delay longer in seeking medical 
help when ailing), as well as to the greater number of programs and 
activities available to women in the primary health care sphere.
The predominance of young adults observed in the present cases 
is consistent with other reports17,29,30,32,33,35,37,38. This population group 
is more vulnerable to the risk of exclusion from the production cycle 
as a result of the disease and to the sequelae and stigma associated 
with leprosy39. The percentage of individuals aged between 0 and 
14 years afflicted by the disease may be a sign of active and recent 
transmission of the endemic, with under 15s being continuously 
exposed to the bacillus in the environment where they live4. This 
result also exposes the passive stance of local health services and 
limited efforts to actively identify cases24 or implement other means 
of health surveillance.
Some Brazilian studies have confirmed the predominance of the 
clinical PB form29,35,37, whereas others have reported a predominance 
of MB19,32,33,38,40. In the present study, the PB clinical form was most 
prevalent in both study periods. Surprisingly, no increase in the 
proportion of PB cases was identified between the two periods, 
where an increase can usually be expected when a large increase in 
the number of cases detected occurs.
Disability grading at diagnosis is extensively used as an 
epidemiological indicator and as a tool for clinical assessment. The 
increase in the percentage of cases with DG ratings at diagnosis 
points to the probable involvement of health services fulfilling and 
performing this control action more effectively. The value obtained 
for this parameter is regarded as regular as a rating of health care 
quality and for monitoring results of the LCA5.
The high percentage of cases lacking disability rating records, 
especially during the preintegration period, attests to the fact that 
physical disability ratings is an LCA, which presents problems in 
quality and registration of assessments27. Although a slight increase 
in the proportion of cases with DG rated at diagnosis was seen in the 
postintegration period in this investigation, other Brazilian studies 
have confirmed a rise, followed by a fall, in the proportion of DG 2 
ratings during the period of postintegration of LCA as a result of the 
measures put in place16,26,30.
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Although a lower number of cases lacking registration of 
disability grade was found during the postintegration period both 
at diagnosis and at end of MDT, indicating a slight improvement 
in this component of the program, the percentage attained remains 
low. The finding of lower proportions of cases with DG ratings at 
the end of MDT is consistent with the results of other studies30,41,42. 
When analyzed individually by year, the DG records do not reach the 
minimum value required to calculate the indicator for proportion of 
DG2 among patients concluding MDT5. This problem may be due, 
in part, to patients not returning to the service for formal discharge. 
however, it is likely that this problem is largely attributed to the low 
importance placed on the registration of follow-up information by 
health care professionals and information services. The low levels of 
registration of physical disability at conclusion of MDT found in the 
present study were similar to those identified by other studies30,42. This 
limited checking of DG may have resulted from under-registration 
of data and indicates that this activity has not yet been incorporated 
satisfactorily into the routine practice of the services.
The domiciliary contact examinations for new cases diagnosed 
is one of the main strategies of achieving early diagnosis and help 
reduce transmission of the disease43,44.
According to the WhO, estimated risk of relapse after 
introduction of MDT is 1.1% for PB and 0.8% for MB45. With 
regard to the admission of relapsing cases, the number of relapses 
exceeded expected rates, a finding which might be attributed to 
the organizational structure of the health services46, alcohol abuse, 
nonadherence to treatment47,48, diagnostic failure, or to the fact that 
individuals treated as PB can subsequently develop generalized MB 
lesions after partial improvement in signs and symptoms49.
Akin to the findings of the present study, an assessment of 
integration of LCP into PhC in Betim, Minas Gerais, reported that 
the surveillance of contacts had not been adequately addressed. 
Although the program had made advances on other aspects, the lack 
of registration precluded comparison between contact examination 
coverage before and after integration30.
Consequently, the contact examination was deemed a poor 
indicator in the cited study for not having attained 50% contact 
examination coverage5, reflecting a similar situation for the indicator 
proportion of contacts examined in the present study (37%). Low 
coverage of contacts examined also was found by other studies, which 
reported rates ranging from 11.8% to 46%42,50,51. Compared with the 
regular range for the parameter, between 50% and 74.9% of contacts 
examined5, Dessunti52 and Fuzikawa30 obtained values of 51% and 
61.7%, respectively. These values were close to the means found 
for Brazil (54%) and State of Sergipe (61.8%) in a national survey 
assessing the years 2001 to 2008. These results served to highlight 
the shortcomings of this control action in Brazil. Only the States of 
São Paulo and Espírito Santo attained proportions deemed good for 
the parameter, registering 78.3% and 75.5% of contacts examined, 
respectively53. however, a higher level of local organization and more 
effective priority given to contact surveillance have led to higher rates in 
some Brazilian municipalities such as Fortaleza, State of Ceará, where, 
in a single year, the contact examination coverage increased to 76% as a 
result of an integral care program for those with leprosy in the region54.
In terms of number of examined contacts registered, the 
postintegration period showed a statistically significant increase in 
the number of cases detected by contact examinations, reiterating 
the fundamental importance of this activity.
Finally, another relevant finding was the reduction in percentage 
of treatment default during the postintegration period. however, it 
should be noted that this percentage is limited in that it does not 
take into account patient cohorts but, rather, patient outcomes on 
the register each year.
The raw overall rates of leprosy detection in Aracaju were higher 
than the rates reported for Brazil as a whole, thus confirming the 
seriousness of the local epidemic. The shifts observed during the years 
studied indicated an increase in the rates of detection in general, and 
among individuals younger than 15 years, for the period following 
integration of the leprosy control actions in the municipality, 
suggesting increased access to health services. The lower number of 
defaults indicate higher adherence to treatment, suggesting improved 
access and presumably greater treatment quality after integration of 
the LCP in PhC.
however, the other operational indicators show that the family 
health care services have not remedied the previous shortcomings 
in actions pivotal to achieving the envisaged outcome and impact of 
the leprosy program, namely, surveillance of contacts and disability 
diagnosis and prevention activities. The performance profile of the 
leprosy program observed in this study resembles that of several other 
Brazilian municipalities studied, showing that family health care has 
a long way to go to achieve its goals of effective integration, even 
for a priority target such as leprosy after many years of integration. 
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